Olmesartan medoxomil ameliorates sciatic nerve regeneration in diabetic rats

Hiroaki Nakamura,Yuki Domon,Tatsuya Inoue,Naohisa Arakawa,Tomihisa Yokoyama
DOI: https://doi.org/10.1097/WNR.0b013e32833283e6
2009-10-28
Neuroreport
Abstract:To evaluate the effect of angiotensin II type1 receptor blocker on nerve regeneration delay in diabetic rats, nerve regeneration was monitored by a pinch test on the crushed sciatic nerves of streptozotocin-induced diabetic rats. Nerve regeneration was significantly delayed in diabetic rats and was partly ameliorated by treatment with olmesartan medoxomil (3 mg/kg/day, orally). In the ipsilateral dorsal root ganglia, the mRNA level of insulin-like growth factor-1 and ciliary neurotrophic factor (CNTF) was downregulated, whereas the mRNA level of neurotrophin-3 and CNTF receptor was upregulated. Olmesartan medoxomil significantly enhanced the CNTF expression. These results showed that angiotensin II type1 receptor blocker treatment is effective on nerve regeneration delay in diabetic animals and may provide an effective therapy for clinical diabetic neuropathy.
What problem does this paper attempt to address?